Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes

Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes

Introduction: Malignant pleural mesothelioma (MPM) is a rare malignancy with a poor prognosis. While treatment with a platinum-based chemotherapy is the standard of care, many patients have rapid progression of disease with a median overall survival of ~12 months. Limited data exist about the genomi...

Full description

Bibliographic Details
Main Authors: Paul Markowitz, Malini Patel, Roman Groisberg, Joseph Aisner, Salma K. Jabbour, Subhajyoti De, Shridar Ganesan, Jyoti Malhotra
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Mesothelioma
Genomic
Mutation burden
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294220300678

Similar Items

Similar Items